Clinical Trial Update: TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating TMZ plus Olaparib for MGMT hypermethylated colorectal cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Olaparib (Olaparib)
• TMZ (temozolomide)

Snippet

Sponsor: Yale University | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-01-30